Published in Breast Cancer Res on March 07, 2000
Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol (2009) 4.07
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell (2007) 3.40
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab. Cancer Biol Ther (2009) 2.37
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene (2010) 1.88
SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am J Pathol (2007) 1.79
The role of Src in solid tumors. Oncologist (2009) 1.72
Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Mol Cancer Ther (2010) 1.67
Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol (2004) 1.60
SRC: a century of science brought to the clinic. Neoplasia (2010) 1.58
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene (2008) 1.57
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Br J Cancer (2009) 1.38
Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res (2008) 1.35
Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Mol Cell Biol (2006) 1.34
c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Cell Signal (2008) 1.28
The spatiotemporal pattern of Src activation at lipid rafts revealed by diffusion-corrected FRET imaging. PLoS Comput Biol (2008) 1.27
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal (2008) 1.27
Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol (2010) 1.26
Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res (2010) 1.24
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? Breast Cancer Res (2001) 1.17
Regulation of gap junctions by tyrosine protein kinases. Biochim Biophys Acta (2004) 1.15
Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med (2012) 1.13
Tyrosine kinase signalling in breast cancer. Breast Cancer Res (2000) 1.10
Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation. J Biol Chem (2006) 1.09
The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors. Mol Cell Biol (2006) 1.07
Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons. Neurobiol Dis (2008) 1.05
The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene (2008) 1.02
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene (2011) 1.02
Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk. Mol Cell Biol (2005) 1.02
SAMNet: a network-based approach to integrate multi-dimensional high throughput datasets. Integr Biol (Camb) (2012) 0.98
EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK. Transl Oncol (2012) 0.96
Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing. Invest Ophthalmol Vis Sci (2011) 0.95
PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase. Cancer Res (2010) 0.95
A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC. PLoS Genet (2007) 0.95
FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells. Proc Natl Acad Sci U S A (2006) 0.95
Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. Br J Cancer (2008) 0.93
Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells. BMC Cancer (2013) 0.92
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Kidney Int (2016) 0.90
Cellular functions regulated by phosphorylation of EGFR on Tyr845. Int J Mol Sci (2013) 0.89
Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival. J Biol Chem (2011) 0.88
A comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells. PLoS One (2013) 0.88
Drosophila Abelson kinase mediates cell invasion and proliferation through two distinct MAPK pathways. Oncogene (2010) 0.88
Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer. BMC Cancer (2010) 0.87
Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases. Infect Immun (2010) 0.83
Synthesis and cytotoxic evaluation of novel 3-substituted derivatives of 2-indolinone. Iran J Pharm Res (2012) 0.83
Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response. Mamm Genome (2008) 0.83
EGF-receptor phosphorylation and downstream signaling are activated by benzo[a]pyrene 3,6-quinone and benzo[a]pyrene 1,6-quinone in human mammary epithelial cells. Toxicol Appl Pharmacol (2009) 0.82
ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation. Oncogene (2013) 0.82
Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma. PLoS One (2012) 0.82
Spermine, a molecular switch regulating EGFR, integrin β3, Src, and FAK scaffolding. Cell Signal (2011) 0.82
Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal. Proc Natl Acad Sci U S A (2015) 0.82
Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. Oncotarget (2015) 0.82
SRC-mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human bronchial epithelial cells. Environ Health Perspect (2014) 0.81
Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants. World J Clin Oncol (2014) 0.81
Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation. Proc Natl Acad Sci U S A (2012) 0.80
The role of SRC family kinases in prostate cancer. Transl Oncogenomics (2007) 0.80
Ductal barriers in mammary epithelium. Tissue Barriers (2013) 0.80
Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk. PLoS One (2013) 0.79
Tyrosine kinase signalling in breast cancer: modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates. Breast Cancer Res (2000) 0.78
Integrated gene networks in breast cancer development. Funct Integr Genomics (2010) 0.78
The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation. PLoS One (2015) 0.78
Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes. Drug Des Devel Ther (2017) 0.78
Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment. J Cancer Res Clin Oncol (2011) 0.77
Dynamic recruitment of protein tyrosine phosphatase PTPD1 to EGF stimulation sites potentiates EGFR activation. PLoS One (2014) 0.77
Differentiation-dependent PTPIP51 expression in human skeletal muscle cell culture. J Histochem Cytochem (2009) 0.77
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs. Biomed Res Int (2016) 0.75
Expression, purification, and bioactivity of GST-fused v-Src from a bacterial expression system. J Zhejiang Univ Sci B (2006) 0.75
MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway. Oncotarget (2017) 0.75
JunD/AP-1 antagonizes the induction of DAPK1 to promote the survival of v-Src transformed cells. J Virol (2016) 0.75
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab? Ther Adv Med Oncol (2013) 0.75
Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun (2016) 0.75
Src Family Kinases in Brain Edema After Acute Brain Injury. Acta Neurochir Suppl (2016) 0.75
Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk. World J Biol Chem (2016) 0.75
LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients. Oncotarget (2016) 0.75
Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. Proc Natl Acad Sci U S A (2015) 0.75
Characterization of the potency of epidermal growth factor (EGFR)-DNA targeting combi-molecules containing a hydrolabile carbamate at the 3-position of the triazene chain. Invest New Drugs (2010) 0.75
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science (1988) 35.59
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (1985) 9.12
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta (1994) 4.92
Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol (1998) 4.22
Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol (1998) 4.09
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Science (1987) 3.93
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem (1999) 3.91
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J (1996) 3.59
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 3.43
Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem (1999) 3.42
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res (1998) 3.39
Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature (1995) 2.97
Signal characteristics of G protein-transactivated EGF receptor. EMBO J (1997) 2.88
EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell (1999) 2.72
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature (1998) 2.62
ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem (1999) 2.41
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem (1996) 2.39
Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol (1997) 2.39
Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1984) 2.30
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci U S A (1995) 2.29
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature (1997) 2.20
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev (1994) 2.05
The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci U S A (1994) 2.05
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol (1994) 2.03
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci U S A (1992) 1.98
Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res (1997) 1.97
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
The regulation and expression of c-myc in normal and malignant cells. Annu Rev Immunol (1986) 1.90
Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J (1996) 1.85
DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol Cell Biol (1995) 1.85
Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer (1995) 1.81
Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J Biol Chem (1995) 1.81
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol (1993) 1.72
c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res (1999) 1.71
Hematopoietic receptor complexes. Annu Rev Biochem (1996) 1.67
Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem (1998) 1.64
Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol Cell Biol (1988) 1.59
pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol Cell Biol (1989) 1.56
Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis. Mol Cell Biol (1989) 1.54
Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog (1998) 1.54
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J (1999) 1.54
EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev (1993) 1.43
Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene (1993) 1.34
STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. Blood (1999) 1.29
Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front Biosci (1997) 1.28
Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem (1998) 1.27
Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor. J Biol Chem (1997) 1.22
Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem (1999) 1.11
Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer. Anticancer Res (1999) 1.11
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer (1991) 1.11
Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential. Oncogene (1998) 1.04
C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells. Biochem Biophys Res Commun (1998) 1.00
Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. Oncogene (1995) 0.93
Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF. Carcinogenesis (1999) 0.91
A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer? Biochemistry (1997) 0.86
Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors. Breast Cancer Res Treat (1990) 0.83
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem (1999) 3.91
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 3.43
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin. J Virol (1984) 3.18
Red-shifted excitation mutants of the green fluorescent protein. Biotechnology (N Y) (1995) 2.85
A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts. J Cell Biol (1990) 2.41
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci U S A (1995) 2.29
Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein. Gene (1996) 2.21
c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol (1995) 2.06
Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol (1997) 1.97
Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene (2001) 1.89
Transmission of hepatitis C within Australian prisons. Med J Aust (1999) 1.89
A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br (2003) 1.78
Application of a protein-blotting procedure to the study of human glucocorticoid receptor interactions with DNA. Proc Natl Acad Sci U S A (1987) 1.73
c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res (1999) 1.71
c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene (2006) 1.69
p60c-src activity detected in the chromaffin granule membrane. Biochem Biophys Res Commun (1986) 1.62
Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol Cell Biol (1988) 1.59
Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone. J Clin Gastroenterol (2001) 1.56
pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol Cell Biol (1989) 1.56
Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature (1985) 1.55
Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog (1998) 1.54
Purification and properties of beta-isopropylmalate dehydrogenase. J Biol Chem (1969) 1.41
Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X) Med Pediatr Oncol (1991) 1.41
Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol (2001) 1.41
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res (1999) 1.37
Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol Cell Biol (1998) 1.32
Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src. J Virol (1983) 1.31
Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front Biosci (1997) 1.28
Identification of chromaffin granule-binding proteins. Relationship of the chromobindins to calelectrin, synhibin, and the tyrosine kinase substrates p35 and p36. J Biol Chem (1987) 1.27
Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor. J Biol Chem (1997) 1.22
Effect of butyrolactone I on the producing fungus, Aspergillus terreus. Appl Environ Microbiol (1998) 1.21
Localization of conserved and nonconserved epitopes within the Rous sarcoma virus-encoded src protein. J Virol (1986) 1.19
Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation. Mol Cell Biol (1994) 1.16
Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J Cell Sci (2001) 1.14
Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene (2006) 1.14
Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Oncogene (1992) 1.14
Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors. Oncogene (1993) 1.12
Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. J Biol Chem (1994) 1.12
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Angiographic diagnosis of anomalous coronary artery in tetralogy of Fallot. Br Heart J (1993) 1.10
Tyrosine phosphorylation of G protein alpha subunits by pp60c-src. Proc Natl Acad Sci U S A (1992) 1.10
Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells. Oncogene (1988) 1.10
The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src. Mol Cell Biol (1993) 1.06
A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma. Mol Cell Biol (1994) 1.05
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene (2011) 1.02
Overexpression of c-src enhances beta-adrenergic-induced cAMP accumulation. Proc Natl Acad Sci U S A (1990) 1.01
Two SH2 domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein. J Biol Chem (1995) 0.96
Electroconvulsive treatment induces a rapid and transient increase in tyrosine phosphorylation of a 40-kilodalton protein associated with microtubule-associated protein 2 kinase activity. J Neurochem (1991) 0.96
c-Src tyrosine phosphorylation of epidermal growth factor receptor, P190 RhoGAP, and focal adhesion kinase regulates diverse cellular processes. Chem Rev (2001) 0.95
Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line. J Biol Chem (2000) 0.94
Gonadotropin-releasing hormone pulses are required to maintain activation of mitogen-activated protein kinase: role in stimulation of gonadotrope gene expression. Endocrinology (1998) 0.93
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Cancer Res (1987) 0.93
Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. Oncogene (1990) 0.93
Monoclonal antibodies to oncoproteins. Methods Enzymol (1995) 0.92
Co-occurrence of aflatoxins B1, B2, G1, G2, zearalenone and fumonisin B1 in Brazilian corn. Food Addit Contam (2001) 0.91
Prognostic value of posterior wall thickness in childhood dilated cardiomyopathy and myocarditis. Eur Heart J (1996) 0.88
Matrix mineralization in hypertrophic chondrocyte cultures. Beta glycerophosphate increases type X collagen messenger RNA and the specific activity of pp60c-src kinase. Bone Miner (1992) 0.87
Tyrosine kinases are required for catecholamine secretion and mitogen-activated protein kinase activation in bovine adrenal chromaffin cells. J Neurochem (1996) 0.87
Monoclonal antibodies specific for the virion polypeptide, p27, of avian retroviruses. Hybridoma (1984) 0.87
Anticonvulsant activity of essential oils and active principles from chemotypes of Lippia alba (Mill.) N.E. Brown. Biol Pharm Bull (2000) 0.87
Modulation of pp60c-src tyrosine kinase activity during secretion in stimulated bovine adrenal chromaffin cells. J Neurosci Res (1989) 0.86
Reduced tyrosine kinase specific activity is associated with hypophosphorylation of pp60c-src in cells infected with avian erythroblastosis virus. Proc Natl Acad Sci U S A (1987) 0.85
Roles for protein kinase C and mitogen-activated protein kinase in nicotine-induced secretion from bovine adrenal chromaffin cells. J Neurochem (1997) 0.84
Overexpression of pp60c-src is associated with altered regulation of adenylyl cyclase. Cell Signal (1992) 0.84
Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res (2000) 0.84
Inhibition of the tyrosine kinase activity of v-src, v-fgr, and v-yes gene products by a monoclonal antibody which binds both amino and carboxy peptide fragments of pp60v-src. J Virol (1987) 0.84
Unicystic ameloblastoma in a child: a differential diagnosis from the dentigerous cyst and the inflammatory follicular cyst. J Dent Child (Chic) (2008) 0.84
Activation of Fyn tyrosine kinase upon secretagogue stimulation of bovine chromaffin cells. J Neurosci Res (1996) 0.83
[Disseminated cutaneous leishmaniasis due to Leishmania viannia braziliensis in the state of Maranhão, Brazil]. Rev Soc Bras Med Trop (1994) 0.83
Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP. J Virol (1995) 0.83
Genetic and environmental influences on atopic immune response in early life. J Investig Allergol Clin Immunol (2000) 0.82
pp60c-src enhances the acetylcholine receptor-dependent catecholamine release in vaccinia virus-infected bovine adrenal chromaffin cells. J Neurochem (1994) 0.81
Fractionation of sulphite spent liquor for biochemical processing using ion exchange resins. J Biotechnol (2012) 0.80
Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children. Endocrinology (1998) 0.80
Structural and functional motifs of the Rous sarcoma virus src protein. Gene Amplif Anal (1986) 0.80
Phosphorylation of the p190 RhoGAP N-terminal domain by c-Src results in a loss of GTP binding activity. FEBS Lett (2000) 0.80
Efficacy of a new formulation of Bacillus sphaericus 2362 against Culex quinquefasciatus (Diptera:Culicidae) in Montes Claros, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz (1998) 0.79
Spontaneous regional healing of extensive skin lesions in diffuse cutaneous Leishmaniasis (DCL). Rev Soc Bras Med Trop (1995) 0.79
Phosphotyrosine phosphatase activity associated with c-Src in large multimeric complexes isolated from adrenal medullary chromaffin cells. Biochem J (1997) 0.79
Insulin and phorbol ester induce distinct phosphorylations of pp60c-src in the BC3H-1 murine myocyte cell line. Oncogene (1989) 0.78
Signal transduction defects in growth hormone insensitivity. Acta Paediatr Suppl (1999) 0.78
Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology (1998) 0.78
Action of selective serotonin reuptake inhibitor on aggressive behavior in adult rat submitted to the neonatal malnutrition. Arq Neuropsiquiatr (2001) 0.77
Effect of growth hormone and induced IGF-I release on germ cell population and apoptosis in the bovine testis. Theriogenology (1999) 0.76
Identification of the in vitro phosphorylation sites on Gs alpha mediated by pp60c-src. Biochem J (1995) 0.76
Growth hormone induces tyrosine phosphorylation but does not alter insulin-like growth factor-I gene expression in human IM9 lymphocytes. J Mol Endocrinol (1994) 0.76
Fidelity of initiation of protein synthesis after premature chain termination in polarity mutants. J Bacteriol (1969) 0.75
Field studies with the bacterial larvicide INPALBAC for Simulium spp. control in Rio Grande do Sul, Brazil. Mem Inst Oswaldo Cruz (1999) 0.75
[Functional anatomy of the junction of the left atrium and the pulmonary veins]. Arq Bras Cardiol (1994) 0.75
[Emergency valvuloplasty with a balloon catheter of a tricuspid bioprosthesis in Ebstein's anomaly]. Arq Bras Cardiol (1994) 0.75
[A cerebrovascular stroke in a child with an anomalous origin of the left coronary artery]. Arq Bras Cardiol (1994) 0.75
Available pathways database (APD): an essential resource for combinatorial biology. J Nat Prod (2000) 0.75
[Clinical librarianship in a hospital community]. AMB Rev Assoc Med Bras (1987) 0.75
Some environmental and biological factors influencing the activity of entomopathogenic Bacillus on mosquito larvae in Brazil. Mem Inst Oswaldo Cruz (1996) 0.75
[Predictive value of reactive strips in urinary infection]. Acta Med Port (2002) 0.75
[Evaluation of outpatient care for people with HIV/AIDS in Rio de Janeiro, from the user's perspective]. Cad Saude Publica (2000) 0.75
[Characterization of the cases of domestic violence against women assisted in 2 public hospitals of Rio de Janeiro]. Cad Saude Publica (2000) 0.75
[The origin of patients who are carriers of diffuse cutaneous leishmaniasis (DCL) in the state of Maranhão, Brazil]. Rev Soc Bras Med Trop (1993) 0.75
Fate of Bacillus sphaericus after ingestion by the predator Belostoma micantulum (Hemiptera: Belostomatidae). Mem Inst Oswaldo Cruz (1996) 0.75
A novel negative imaging technique for accurate localization of stainable proteins on complex two-dimensional autoradiograms. Electrophoresis (1997) 0.75